Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway
Alessandra D’Abramo, Serena Vita, Gaetano Maffongelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Showing 23 citing articles:

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 1012-1017
Closed Access | Times Cited: 11
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience
Alessandra D’Abramo, Serena Vita, Alessia Beccacece, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
Daniele Focosi, Fabrizio Maggi, Alessandra D’Abramo, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 55-59
Open Access | Times Cited: 17
Intruders or protectors – the multifaceted role of B cells in CNS disorders
James W. Aspden, Matthew A. Murphy, Rommi D. Kashlan, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Risk prediction and early intervention strategies for persistent SARS-CoV-2 infection in patients with non-Hodgkin lymphoma: a retrospective cohort study
Wailong Zou, Jia Zhang, Yulin Li, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
Serena Vita, Alessandra D’Abramo, Andrea Coppola, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations
Francesco Passamonti, Emanuele Nicastri, Alice Di Rocco, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 3-15
Open Access | Times Cited: 19
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín‐Quirós, et al.
Cytotherapy (2023) Vol. 26, Iss. 1, pp. 25-35
Closed Access | Times Cited: 11
Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
Vincenzo Scaglione, Salvatore Rotundo, Nadia Marascio, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study
Vasiliki Georgakopoulou, Aikaterini Gkoufa, Sotiria Makrodimitri, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 7
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 2
The unmet need for COVID-19 treatment in immunocompromised patients
Alessandra D’Abramo, Serena Vita, Emanuele Nicastri
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study
Haruka Shimazu, Daiki Wada, Shuhei Maruyama, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Rosaria Talarico, Giuseppe A. Ramirez, Sofia Barreira, et al.
Clinical and Experimental Rheumatology (2023)
Open Access | Times Cited: 5
A Descriptive, Retrospective Analysis of COVID-19 Passive Antibody Therapy and Its Effects on Morbidity and Mortality in Patients Receiving B-Cell-Depleting Therapies
Sonia K Gentile, Liam R. Sullivan, Heather D. Brooks, et al.
Diseases (2024) Vol. 12, Iss. 2, pp. 33-33
Open Access | Times Cited: 1
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
Tal Brosh‐Nissimov, Nir Maaravi, Daniel Leshin-Carmel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight
Claudia Ielo, Francesca Fazio, Serena Rocchi, et al.
Leukemia Research Reports (2023) Vol. 21, pp. 100399-100399
Open Access | Times Cited: 2
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
Serena Vita, Emanuela Giombini, Patrizia De Marco, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024043-e2024043
Open Access
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments
Flavia Sanmartin, Eugenia Magrini, Emanuele Rando, et al.
American Journal of Case Reports (2024) Vol. 25
Open Access
Treatment Modalities for immunocompromised patients with Persistent, symptomatic COVID-19 Infection, literature review, and Recommendations
Sopiko Gogia, Valiko Begiashvili, Ola A Al-Ewaidat, et al.
Authorea (Authorea) (2023)
Open Access
Antineoplastics

Reactions Weekly (2022) Vol. 1937, Iss. 1, pp. 55-55
Closed Access
Page 1

Scroll to top